COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

Background: COVID-19 vaccination has been recommended for severe asthmatics. We aimed to evaluate the safety, tolerability, and impact on disease control and patient’s quality of life of the mRNA SARS-CoV-2/COVID-19 vaccine in severe asthma patients regarding biologic treatment. Methods: Severe asth...

Descripción completa

Detalles Bibliográficos
Autores principales: Caminati, Marco, Guarnieri, Gabriella, Batani, Veronica, Scarpieri, Elena, Finocchiaro, Anita, Chieco-Bianchi, Fulvia, Senna, Gianenrico, Vianello, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402597/
https://www.ncbi.nlm.nih.gov/pubmed/34451978
http://dx.doi.org/10.3390/vaccines9080853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402597/
https://www.ncbi.nlm.nih.gov/pubmed/34451978
http://dx.doi.org/10.3390/vaccines9080853

Ejemplares similares